LIAISON® SARS-CoV-2 Diagnostic Solution
COVID-19 management just got easier.
Diasorin is helping prevent the widespread diffusion of SARS-CoV-2 with automated, high-throughput SARS-CoV-2 serology testing solutions.
LIAISON® SARS-CoV-2 Ag
For the quantitative determination of SARS-CoV-2 nucleocapsid protein antigen in nasal swab (NS), nasopharyngeal swab (NPS), in individuals suspected to have COVID-19 by their healthcare provider within the first ten days from the onset of symptoms and in nasopharyngeal swab (NPS) in asymptomatic subjects.
LIAISON® SARS-CoV-2 TrimericS IgG
For the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples.
Background
COVID-19 is a contagious viral illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to accurately diagnose COVID-19 specialized testing is needed as many of its symptoms, are similar to those of a common flu. Some individuals have no symptoms at all whereas others may experience fever, cough, sore throat, loss of the sense of smell, general weakness and fatigue and muscular pain. In the most severe cases, severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock, all of which potentially lead to death.
Early and accurate diagnosis, together with confirming vaccine effectiveness, are crucial to supporting medical decisions and preventing the diffusion of SARS-CoV-2.
How it works
The LIAISON® SARS-CoV-2 assays are highly effective chemiluminescence testing solutions to help contain the COVID-19 pandemic. The exclusive immunoassays provide both a fully automated diagnosis of COVID-19 in suspected cases and the quantitative determination of the immune status of infected and vaccinated individuals.
Fully automated Ag and IgG testing
Early diagnosis on a high-throughput platform
Use within the first ten days of the onset of symptoms, LIAISON® SARS-CoV-2 Antigen Ag delivers 136 tests per hour. The all-in-one process runs on the fully automated LIAISON® XL chemiluminescence analyzer for greater testing efficiency and overall accuracy.
Capture the entire population of antibodies
The high sensitivity and specificity of our innovative IgG antibody detection assay ensures fast, accurate results. In addition, because the capture antigen is the Trimeric Spike protein, it offers greater diagnostic precision and better detection of the antibodies.
Innovative bio-sampling approach to better diagnostics
With the high performance of our exclusive assays and their all-inclusive Reagent Integral format, Diasorin guarantees consistent, high-quality diagnostic results while preventing waste.
Why use LIAISON® SARS-CoV-2 Diagnostic Solution
Effective, high-throughput SARS-CoV-2 testing solutions.
Powerful chemiluminescence analysis
Early detection of the SARS-CoV-2 antigen and the determination of anti-SARS-CoV-2 IgG antibody with results in less than an hour.
Improve SARS-CoV-2 immuno-monitoring
A quantitative assay for the detection of IgG antibodies anti-Trimeric Spike glycoprotein of SARS-CoV-2.
Address increased demand peaks
Enjoy continuous, automatic loading of high-quality specialty assays within a completely traceable process that ensures absolute reliability.
To be used on
Designed for both specialty and routine tests, the LIAISON® XL immunoassay analyzer helps your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.